Scandinavian Journal of Urology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trials
CONCLUSION: MHRT delivers similar therapeutic outcomes compared to CFRT in terms of tumour control and late toxicity for intermediate-risk PCa patients. Slightly more acute transient toxicity could be tolerated in favour of a shorter treatment course. UHRT should be regarded as an optional treatment for patients with low- and intermediate-risk disease applied at experienced centres in concordance with international and national guidelines.PMID:37338209 | DOI:10.2340/sju.v58.7719 (Source: Scandinavian Journal of Urology)
Source: Scandinavian Journal of Urology - June 20, 2023 Category: Urology & Nephrology Authors: Oscar Lilleby Peter Meidahl Petersen Gedske Daugaard Katharina Anne Perell Source Type: research